FDA approves Ventak P3 defibrillator:
This article was originally published in Clinica
The US FDA has approved Guidant CPI's Ventak P3 implantable defibrillator and a new software module for the model 2035 handheld programmer. The Ventak P3 has the same features as the P2 but is the size and shape of the smaller Ventak PRx III which was released in May (see Clinica No 645, p 18). The new software allows both P2 and P3 devices to be set up and monitored using the same programmer.